Shay Shemesh - 15 Mar 2023 Form 4 Insider Report for Nuvectis Pharma, Inc. (NVCT)

Signature
/s/ Shay Shemesh
Issuer symbol
NVCT
Transactions as of
15 Mar 2023
Net transactions value
+$7,176
Form type
4
Filing time
17 Mar 2023, 08:31:20 UTC
Previous filing
13 Jan 2023
Next filing
22 Mar 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCT Common Stock Purchase $7,176 +670 +0.05% $10.71 1,361,535 15 Mar 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the weighted average purchase price. The range of prices for the shares purchased was $9.94 to $11.00. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.
F2 Includes 48,399 shares of restricted stock and 175,000 restricted stock units.